A selective SND1 inhibitor, 3′,5′-deoxythymidine bisphosphate (pdTp), inhibited the AEG-1-induced increased proliferation of human HCC cells and effectively reduced the tumor burden in human xenograft models of subcutaneous or orthotopic HCC [166,173]. Here, SND1 is linked to neoplasm.